Tyrosine Kinase Inhibitor Lapatinib Inhibits Cell Growth and Induces Apoptosis in Pancreatic Carcinoma Cells, and Exerts Synergistic Effects With Conventional Chemotherapy Agents

被引：0
|
作者：
Singla, S. [1 ]
Pippin, J. A. [1 ]
Drebin, J. A. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells
    Sun, Jiping
    Xie, Liyi
    Lv, Jing
    Zhang, Wenjing
    Lv, Jia
    Liang, Yu
    Geng, Yingzhou
    Li, Xudong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (04) : 6709 - 6717
  • [2] Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on NSCLC carcinoma cell lines
    Commo, Frederic
    Olaussen, Ken A.
    Tailler, Maximilien
    Lacroix, Ludovic
    Vitale, Ilio
    Raza, Syed Q.
    Richon, Catherine
    Dessen, Philippe
    Lazar, Vladimir
    Kroemer, Guido
    Soria, Jean-Charles
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S595 - S596
  • [3] Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines
    K A Olaussen
    F Commo
    M Tailler
    L Lacroix
    I Vitale
    S Q Raza
    C Richon
    P Dessen
    V Lazar
    J -C Soria
    G Kroemer
    Oncogene, 2009, 28 : 4249 - 4260
  • [4] Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines
    Olaussen, K. A.
    Commo, F.
    Tailler, M.
    Lacroix, L.
    Vitale, I.
    Raza, S. Q.
    Richon, C.
    Dessen, P.
    Lazar, V.
    Soria, J-C
    Kroemer, G.
    ONCOGENE, 2009, 28 (48) : 4249 - 4260
  • [5] The tyrosine kinase inhibitor ZD6474 inhibits cell proliferation and induces apoptosis in malignant mesothelioma
    Betta, Pier-Giacomo
    Castagneto, Bruno
    Libener, Roberta
    Schillaci, Francesca
    Salvio, Michela
    Bottero, Guido
    Orecchia, Sara
    ANNALS OF ONCOLOGY, 2006, 17 : 57 - 58
  • [6] The Src inhibitor dasatinib inhibits breast cancer cell growth in vitro and exerts synergistic effects with bisphosphonates
    Journe, Fabrice
    Kheddoumi, Naima
    Chaboteaux, Carole
    Sotiriou, Christos
    Piccart, Martine
    Body, Jean-Jacques
    BONE, 2008, 42 : S96 - S97
  • [7] Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer
    Singla, Smit
    Pippin, James A.
    Drebin, Jeffrey A.
    ONCOLOGY REPORTS, 2012, 28 (06) : 2211 - 2216
  • [8] EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5
    Modjtahedi, H
    Affleck, K
    Stubberfield, C
    Dean, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (02) : 335 - 342
  • [9] Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
    Bruns, CJ
    Solorzano, CC
    Harbison, MT
    Ozawa, S
    Tsan, R
    Fan, D
    Abbruzzese, J
    Traxler, P
    Buchdunger, E
    Radinsky, R
    Fidler, IJ
    CANCER RESEARCH, 2000, 60 (11) : 2926 - 2935
  • [10] Rack1 inhibits growth and induces apoptosis of human colon cells by suppressing the oncogenic Src tyrosine kinase
    Mamidipudi, V
    Miller, L
    Parman, T
    Lee, K
    Cartwright, CA
    GASTROENTEROLOGY, 2005, 128 (04) : A120 - A121
12345